The role of apoptosis in radiation oncology

References

• Akimoto T, Hunter N R, Buchmiller L, Mason K, Ang K K, Milas L. Inverse relationship between epidermal growth factor receptor expression and radiocurability of murine carcinomas. Clinical Cancer Research 1999a; 5: 2884–2890
   PubMed Web of Science ®Google Scholar
• Akimoto T, Kawabe S, Grothey A, Milas L. Low E-cadherin and beta-catenin expression correlates with increased spontaneous and artificial lung metastases of murine carcinomas. Clinical and Experimental Metastasis 1999b; 17: 171–176
   PubMedGoogle Scholar
• Albini A, Noonan D M, Ferrari N. Molecular pathways for cancer angioprevention. Clinical Cancer Research 2007; 13: 4320–4325
   PubMed Web of Science ®Google Scholar
• An J, Chervin A S, Nie A, Ducoff H S, Huang Z. Overcoming the radioresistance of prostate cancer cells with a novel Bcl-2 inhibitor. Oncogene 2007; 26: 652–661
   PubMed Web of Science ®Google Scholar
• Ang K K, Berkey B A, Tu X, Zhang H Z, Katz R, Hammond E H, Fu K K, Milas L. Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Research 2002; 62: 7350–7356
   PubMed Web of Science ®Google Scholar
• Bacq Z, Alexander P. Fundamentals of Radiobiology. Pergamon Press, London 1961
   Google Scholar
• Bao S, Wu Q, McLendon R E, Hao Y, Shi Q, Hjelmeland A B, Dewhirst M W, Bigner D D, Rich J N. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006; 444: 756–760
   PubMed Web of Science ®Google Scholar
• Baumann M, Krause M, Hill R. Exploring the role of cancer stem cells in radioresistance. Nature Reviews Cancer. 2008; 545–554
   Google Scholar
• Beachy S H, Repasky E A. Using extracellular biomarkers for monitoring efficacy of therapeutics in cancer patients: an update. Cancer Immunolology Immunotherapy 2008; 57: 759–775
   PubMed Web of Science ®Google Scholar
• Bentzen S M. Dose painting and theragnostic imaging: Towards the prescription, planning and delivery of biologically targeted dose distributions in external beam radiation oncology. Cancer Treatment and Research 2008; 139: 41–62
   PubMedGoogle Scholar
• Bonner J A, Harari P M, Giralt J, Azarnia N, Shin D M, Cohen R B, Jones C U, Sur R, Raben D, Jassem J, Ove R, Kies M S, Baselga J, Youssoufian H, Amellal N, Rowinsky E K, Ang K K. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. The New England Journal of Medicine 2006; 354: 567–578
   PubMed Web of Science ®Google Scholar
• Brown J M, Attardi L D. The role of apoptosis in cancer development and treatment response. Nature Reviews Cancer 2005; 5: 231–237
   PubMed Web of Science ®Google Scholar
• Brown J M, Wilson G. Apoptosis genes and resistance to cancer therapy: What does the experimental and clinical data tell us. Cancer Biology and Therapy 2003; 2: 477–490
   PubMed Web of Science ®Google Scholar
• Camphausen K, Tofilon P J. Combining radiation and molecular targeting in cancer therapy. Cancer Biology and Therapy 2004; 3: 247–250
   PubMed Web of Science ®Google Scholar
• Cao C, Albert J M, Geng L, Ivy P S, Sandler A, Johnson D H, Lu B. Vascular endothelial growth factor tyrosine kinase inhibitor AZD2171 and fractionated radiotherapy in mouse models of lung cancer. Cancer Research 2006; 66: 11409–11415
   PubMed Web of Science ®Google Scholar
• Chinnaiyan P, Huang S, Vallabhaneni G, Armstrong E, Varambally S, Tomlins S A, Chinnaiyan A M, Harari P M. Mechanisms of enhanced radiation response following epidermal growth factor receptor signaling inhibition by erlotinib (Tarceva). Cancer Research 2005; 65: 3328–3335
   PubMed Web of Science ®Google Scholar
• Chiou S H, Kao C L, Chen Y W, Chien C S, Hung S C, Lo J F, Chen Y J, Ku H H, Hsu M T, Wong T T. Identification of CD133-positive radioresistant cells in atypical teratoid/rhabdoid tumor. PLoS ONE 2008; 3: e2090
   PubMed Web of Science ®Google Scholar
• Coppola J M, Ross B D, Rehemtulla A. Noninvasive imaging of apoptosis and its application in cancer therapeutics. Clinical Cancer Research 2008; 14: 2492–2501
   PubMedGoogle Scholar
• Danial N N, Korsmeyer S J. Cell death: Critical control points. Cell 2004; 116: 205–219
   PubMed Web of Science ®Google Scholar
• Davis D W, McConkey D J, Zhang W, Herbst R S. Antiangiogenic tumor therapy. Biotechniques 2003; 34, 1048–1050,1052,1054 passim
   Google Scholar
• Dewey W C, Ling C C, Meyn R E. Radiation-induced apoptosis: Relevance to radiotherapy. International Journal of Radiation Oncology, Biology, Physics 1995; 33: 781–796
   PubMed Web of Science ®Google Scholar
• Dittmann K, Mayer C, Fehrenbacher B, Schaller M, Raju U, Milas L, Chen D J, Kehlbach R, Rodemann H P. Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase. Journal of Biological Chemistry 2005b; 280: 31182–31189
   PubMed Web of Science ®Google Scholar
• Dittmann K, Mayer C, Rodemann H P. Inhibition of radiation-induced EGFR nuclear import by C225 (Cetuximab) suppresses DNA-PK activity. Radiotherapy and Oncology 2005a; 76: 157–161
   PubMed Web of Science ®Google Scholar
• Endlich B, Radford I R, Forrester H B, Dewey W C. Computerized video time-lapse microscopy studies of ionizing radiation-induced rapid-interphase and mitosis-related apoptosis in lymphoid cells. Radiation Research 2000; 153: 36–48
   PubMed Web of Science ®Google Scholar
• Escriva M, Peiro S, Herranz N, Villagrasa P, Dave N, Montserrat-Sentis B, Murray S A, Franci C, Gridley T, Virtanen I, Garcia de Herreros A. Repression of PTEN phosphatase by Snail1 transcriptional factor during gamma radiation-induced apoptosis. Molecular and Cellular Biology 2008; 28: 1528–1540
   PubMed Web of Science ®Google Scholar
• Eyler C E, Rich J N. Survival of the fittest: Cancer stem cells in therapeutic resistance and angiogenesis. Journal of Clinical Oncology 2008; 26: 2839–2845
   PubMed Web of Science ®Google Scholar
• Ferrara N, Kerbel R S. Angiogenesis as a therapeutic target. Nature 2005; 438: 967–974
   PubMed Web of Science ®Google Scholar
• Gerke V, Moss S E. Annexins: From structure to function. Physiological Reviews 2002; 82: 331–371
   PubMed Web of Science ®Google Scholar
• Haas R L, de Jong D, Valdes Olmos R A, Hoefnagel C A, van den Heuvel I, Zerp S F, Bartelink H, Verheij M. In vivo imaging of radiation-induced apoptosis in follicular lymphoma patients. International Journal of Radiation Oncology, Biology, Physics 2004; 59: 782–787
   PubMed Web of Science ®Google Scholar
• Hambardzumyan D, Becher O J, Holland E C. Cancer stem cells and survival pathways. Cell Cycle 2008a; 7: 1371–1378
   PubMed Web of Science ®Google Scholar
• Hambardzumyan D, Becher O J, Rosenblum M K, Pandolfi P P, Manova-Todorova K, Holland E C. PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo. Genes and Development 2008b; 22: 436–448
   PubMed Web of Science ®Google Scholar
• Hart L S, El-Deiry W S. Invincible, but not invisible: Imaging approaches toward in vivo detection of cancer stem cells. Journal of Clinical Oncology 2008; 26: 2901–2910
   PubMed Web of Science ®Google Scholar
• Held K D. Radiation-induced apoptosis and its relationship to loss of clonogenic survival. Apoptosis 1997; 2: 265–282
   PubMed Web of Science ®Google Scholar
• Herbst R S. Review of epidermal growth factor receptor biology. International Journal of Radiation Oncology, Biology, Physics 2004; 59: 21–26
   PubMed Web of Science ®Google Scholar
• Herbst R S, Bunn P A, Jr. Targeting the epidermal growth factor receptor in non-small cell lung cancer. Clinical Cancer Research 2003; 9: 5813–5824
   PubMed Web of Science ®Google Scholar
• Huang S M, Bock J M, Harari P M. Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck. Cancer Research 1999; 59: 1935–1940
   PubMed Web of Science ®Google Scholar
• Huang S M, Li J, Armstrong E A, Harari P M. Modulation of radiation response and tumor-induced angiogenesis after epidermal growth factor receptor inhibition by ZD1839 (Iressa). Cancer Research 2002; 62: 4300–4306
   PubMed Web of Science ®Google Scholar
• Hugo H, Ackland M L, Blick T, Lawrence M G, Clements J A, Williams E D, Thompson E W. Epithelial – mesenchymal and mesenchymal – epithelial transitions in carcinoma progression. Journal of Cellular Physiology 2007; 213: 374–383
   PubMed Web of Science ®Google Scholar
• Kerr J F, Wyllie A H, Currie A R. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. British Journal of Cancer 1972; 26: 239–257
   PubMed Web of Science ®Google Scholar
• Li L, Wang H, Yang E S, Arteaga C L, Xia F. Erlotinib attenuates homologous recombinational repair of chromosomal breaks in human breast cancer cells. Cancer Research 2008; 68: 9141–9146
   PubMedGoogle Scholar
• LoPiccolo J, Blumenthal G M, Bernstein W B, Dennis P A. Targeting the PI3K/Akt/mTOR pathway: Effective combinations and clinical considerations. Drug Resistance Updates 2008; 11: 32–50
   PubMed Web of Science ®Google Scholar
• Mani S A, Guo W, Liao M J, Eaton E N, Ayyanan A, Zhou A Y, Brooks M, Reinhard F, Zhang C C, Shipitsin M, Campbell L L, Polyak K, Brisken C, Yang J, Weinberg R A. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008; 133: 704–715
   PubMed Web of Science ®Google Scholar
• Meyn R E. Apoptosis and response to radiation: Implications for radiation therapy. Oncology 1997; 11: 349–356, discussion 356,361,365
   PubMedGoogle Scholar
• Meyn R E, Stephens L C, Milas L. Programmed cell death and radioresistance. Cancer Metastasis Reviews 1996; 15: 119–131
   PubMed Web of Science ®Google Scholar
• Mhashilkar A M, Stewart A L, Sieger K, Yang H Y, Khimani A H, Ito I, Saito Y, Hunt K K, Grimm E A, Roth J A, Meyn R E, Ramesh R, Chada S. MDA-7 negatively regulates the beta-catenin and PI3K signaling pathways in breast and lung tumor cells. Molecular Therapy 2003; 8: 207–219
   PubMed Web of Science ®Google Scholar
• Milas L, Fan Z, Andratschke N H, Ang K K. Epidermal growth factor receptor and tumor response to radiation: In vivo preclinical studies. International Journal of Radiation Oncology Biology Physics 2004; 58: 966–971
   PubMed Web of Science ®Google Scholar
• Mu Z, Hachem P, Pollack A. Antisense Bcl-2 sensitizes prostate cancer cells to radiation. The Prostate 2005; 65: 331–340
   PubMedGoogle Scholar
• Murdoch D, Sager J. Will targeted therapy hold its promise? An evidence-based review. Current Opinion in Oncology 2008; 20: 104–111
   PubMed Web of Science ®Google Scholar
• Nishikawa T, Ramesh R, Munshi A, Chada S, Meyn R E. Adenovirus-mediated mda-7 (IL24) gene therapy suppresses angiogenesis and sensitizes NSCLC xenograft tumors to radiation. Molecular Therapy 2004; 9: 818–828
   PubMed Web of Science ®Google Scholar
• Ochs J S. Rationale and clinical basis for combining gefitinib (IRESSA, ZD1839) with radiation therapy for solid tumors. International Journal of Radiation Oncology, Biology, Physics 2004; 58: 941–949
   PubMed Web of Science ®Google Scholar
• Oehler-Jänne C, Jochum W, Riesterer O, Broggini-Tenzer A, Caravatti G, Vuong V, Pruschy M. Hypoxia modulation and radiosensitization by the novel dual EGFR and VEGFR inhibitor AEE788 in spontaneous and related allograft tumor models. Molecular Cancer Therapeutics 2007; 6: 2496–2504
   PubMed Web of Science ®Google Scholar
• Oltersdorf T, Elmore S W, Shoemaker A R, Armstrong R C, Augeri D J, Belli B A, Bruncko M, Deckwerth T L, Dinges J, Hajduk P J, Joseph M K, Kitada S, Korsmeyer S J, Kunzer A R, Letai A, Li C, Mitten M J, Nettesheim D G, Ng S, Nimmer P M, O'Connor J M, Oleksijew A, Petros A M, Reed J C, Shen W, Tahir S K, Thompson C B, Tomaselli K J, Wang B, Wendt M D, Zhang H, Fesik S W, Rosenberg S H. An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 2005; 435: 677–681
   PubMed Web of Science ®Google Scholar
• Onder T T, Gupta P B, Mani S A, Yang J, Lander E S, Weinberg R A. Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Research 2008; 68: 3645–3654
   PubMed Web of Science ®Google Scholar
• Rich J N. Cancer stem cells in radiation resistance. Cancer Research 2007; 67: 8980–8984
   PubMed Web of Science ®Google Scholar
• Rupnow B A, Knox S J. The role of radiation-induced apoptosis as a determinant of tumor responses to radiation therapy. Apoptosis 1999; 4: 115–143
   PubMed Web of Science ®Google Scholar
• Schreck R. Cinemicrographic observations and theoretical considerations on reactions of lymphocytes to x-rays. Radiology 1955; 65: 912–919
   PubMedGoogle Scholar
• Shangary S, Johnson D E. Recent advances in the development of anticancer agents targeting cell death inhibitors in the Bcl-2 protein family. Leukemia 2003; 17: 1470–1481
   PubMedGoogle Scholar
• Shinohara E T, Cao C, Niermann K, Mu Y, Zeng F, Hallahan D E, Lu B. Enhanced radiation damage of tumor vasculature by mTOR inhibitors. Oncogene 2005; 24: 5414–5422
   PubMed Web of Science ®Google Scholar
• Song J. EMT or apoptosis: A decision for TGF-beta. Cell Research 2007; 17: 289–290
   PubMed Web of Science ®Google Scholar
• Steel G G. The case against apoptosis. Acta Oncologica 2001; 40: 968–975
   PubMed Web of Science ®Google Scholar
• Stephens L C, Ang K K, Schultheiss T E, Milas L, Meyn R E. Apoptosis in irradiated murine tumors. Radiation Research 1991; 127: 308–316
   PubMed Web of Science ®Google Scholar
• Stephens L C, Hunter N R, Ang K K, Milas L, Meyn R E. Development of apoptosis in irradiated murine tumors as a function of time and dose. Radiation Research 1993; 135: 75–80
   PubMed Web of Science ®Google Scholar
• Story M D, Voehringer D W, Malone C G, Hobbs M L, Meyn R E. Radiation-induced apoptosis in sensitive and resistant cells isolated from a mouse lymphoma. International Journal of Radiation Biology 1994; 66: 659–668
   PubMed Web of Science ®Google Scholar
• Tanaka T, Munshi A, Brooks C, Liu J, Hobbs M L, Meyn R E. Gefitinib radiosensitizes non-small cell lung cancer cells by suppressing cellular DNA repair capacity. Clinical Cancer Research 2008; 14: 1266–1273
   PubMed Web of Science ®Google Scholar
• Thariat J, Yildirim G, Mason K A, Garden A S, Milas L, Ang K K. Combination of radiotherapy with EGFR antagonists for head and neck carcinoma. International Journal of Clinical Oncology 2007; 12: 99–110
   PubMedGoogle Scholar
• Thiery J P. Epithelial-mesenchymal transitions in tumour progression. Nature Reviews Cancer 2002; 2: 442–454
   PubMed Web of Science ®Google Scholar
• Thiery J P. Epithelial-mesenchymal transitions in development and pathologies. Current Opinion in Cell Biology 2003; 15: 740–746
   PubMed Web of Science ®Google Scholar
• Timke C, Zieher H, Roth A, Hauser K, Lipson K E, Weber K J, Debus J, Abdollahi A, Huber P E. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy. Clinical Cancer Research 2008; 14: 2210–2219
   PubMed Web of Science ®Google Scholar
• Valerie K, Yacoub A, Hagan M P, Curiel D T, Fisher P B, Grant S, Dent P. Radiation-induced cell signaling: Inside-out and outside-in. Molecular Cancer Therapeutics 2007; 6: 789–801
   PubMed Web of Science ®Google Scholar
• Vega S, Morales A V, Ocana O H, Valdes F, Fabregat I, Nieto M A. Snail blocks the cell cycle and confers resistance to cell death. Genes and Development 2004; 18: 1131–1143
   PubMed Web of Science ®Google Scholar
• Verheij M. Clinical biomarkers and imaging for radiotherapy-induced cell death. Cancer Metastasis Reviews. 2008; 471–480
   Google Scholar
• Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. Journal of Immunological Methods 1995; 184: 39–51
   PubMed Web of Science ®Google Scholar
• Wachsberger P, Burd R, Dicker A P. Tumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents: exploring mechanisms of interaction. Clinical Cancer Research 2003; 9: 1957–1971
   PubMed Web of Science ®Google Scholar
• Weil M M, Amos C I, Mason K A, Stephens L C. Genetic basis of strain variation in levels of radiation-induced apoptosis of thymocytes. Radiation Research 1996; 146: 646–651
   PubMedGoogle Scholar
• Wouters B G, Denko N C, Giaccia A J, Brown J M. A p53 and apoptotic independent role for p21waf1 in tumour response to radiation therapy. Oncogene 1999; 18: 6540–6545
   PubMedGoogle Scholar
• Wu A M, Olafsen T. Antibodies for molecular imaging of cancer. Cancer Journal 2008; 14: 191–197
   PubMedGoogle Scholar
• Yin D X, Schimke R T. BCL-2 expression delays drug-induced apoptosis but does not increase clonogenic survival after drug treatment in HeLa cells. Cancer Research 1995; 55: 4922–4928
   PubMed Web of Science ®Google Scholar
• Zhuo W, Wang Y, Zhuo X, Zhang Y, Ao X, Chen Z. Knockdown of Snail, a novel zinc finger transcription factor, via RNA interference increases A549 cell sensitivity to cisplatin via JNK/mitochondrial pathway. Lung Cancer. 2008b; 8–14
   Google Scholar
• Zhuo W L, Wang Y, Zhuo X L, Zhang Y S, Chen Z T. Short interfering RNA directed against TWIST, a novel zinc finger transcription factor, increases A549 cell sensitivity to cisplatin via MAPK/mitochondrial pathway. Biochemical and Biophysical Research Communications 2008a; 369: 1098–1102
   PubMed Web of Science ®Google Scholar